Rheonix to Advance Automated Diagnostic Testing Technology through Strategic Partnership

By: Benzinga
Rheonix, Inc., a developer of fully automated molecular testing solutions, and Life Technologies Corp. (NASDAQ: LIFE ), a global leader in the life sciences tools and diagnostic markets, have entered into a joint development agreement to introduce a molecular testing platform for their Applied Markets business. Technology developed by
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.